Octreotide Scan
Hover over a term you want explained. If you need more details, then click on the term and a new tab will open with a full details page.
What an Octreotide Scan Means in Everyday Medical Language
An Octreotide Scan is a medical imaging test that helps find certain types of tumors in the body. It uses a small amount of a radioactive drug called octreotide, which is similar to a natural hormone called somatostatin. This drug is injected into a vein and travels through the bloodstream. Tumor cells that have special receptors for somatostatin will attract and hold onto the radioactive octreotide. A special camera then detects the radiation from the drug and creates pictures showing where these tumor cells are located.
This scan is often used to find neuroendocrine tumors, such as carcinoid tumors or pancreatic neuroendocrine tumors. It may also be called Somatostatin Receptor Scintigraphy or SRS. Because these names all refer to the same test, it’s helpful to know they mean the same thing when reading medical reports or talking with your care team.
Why the Octreotide Scan Can Matter in Cancer Care
Neuroendocrine tumors can sometimes be hard to find because they may be small or located in places that are difficult to see with regular imaging tests. The Octreotide Scan helps doctors locate these tumors by targeting the somatostatin receptors that many of these tumor cells have. Knowing where tumors are helps doctors plan treatment, monitor how well treatment is working, or check for tumor spread after treatment.
Because the scan highlights tumor cells with somatostatin receptors, it is especially useful for tumors like carcinoid tumors, gastrinomas, glucagonomas, and other neuroendocrine tumors. It can also help detect certain inflammatory conditions like sarcoidosis. However, newer imaging tests using PET scans with different radioactive drugs are sometimes used instead, depending on availability and the specific tumor type.
What Patients Might See or Hear About the Octreotide Scan
If your doctor mentions an Octreotide Scan, you might hear it called by other names like Somatostatin Receptor Scintigraphy or SRS. You may see these terms in your medical reports, visit notes, or educational materials. The scan involves an injection of a radioactive drug followed by imaging with a special camera, usually done over several hours or even days to get the best pictures.
Because the scan is a tool to help find tumors, seeing the term does not mean you have a specific diagnosis or that a particular treatment is planned. It is important to ask your healthcare team what the scan results mean for your personal care and what the next steps might be.
How Doctors Use the Octreotide Scan
Doctors use the Octreotide Scan to locate neuroendocrine tumors that have somatostatin receptors. It can help find the original tumor, check if the cancer has spread, or monitor how well treatment is working. The scan is often part of the diagnosis and staging process and may be repeated during follow-up care.
The radioactive drug used in the scan is usually labeled with indium-111 or technetium-99m, and imaging is done with a gamma camera using a technique called SPECT. Newer scans using PET imaging with different radioactive markers are becoming more common because they can provide clearer images, but the Octreotide Scan remains an important option in many centers.
Common Sources of Confusion and Practical Questions to Ask
The Octreotide Scan may be called by several names, which can be confusing. It’s helpful to know that Octreotide Scan, Somatostatin Receptor Scintigraphy, and SRS all refer to the same test. Also, having this scan does not automatically mean you have cancer or that a specific treatment is planned. It is a diagnostic tool to help doctors understand your condition better.
When discussing the scan with your care team, you might ask: What is the purpose of this scan for my care? How should I prepare for it? What will the results tell us? Are there other imaging tests that might be better for my situation? How will the scan results affect my treatment plan?
How to Read the Term in Context and Next Steps
When you see the term Octreotide Scan in your medical records or hear it mentioned, remember it is one part of your overall care. It is important to understand how this test fits into your diagnosis, treatment, or follow-up. Always ask your healthcare team to explain what the scan results mean for you personally.
This information is educational and does not replace medical advice. The best next step if you have questions about an Octreotide Scan is to talk with your doctor or nurse. They can explain why the scan is recommended, what to expect, and how it will help guide your care.
Sources
Public source information used for this glossary entry includes: